|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 33, 25102-25108, August 18, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 29, 2000, and in revised form, May 22, 2000
Type I signal peptidases (SPases) are required
for the removal of signal peptides from translocated proteins and,
subsequently, release of the mature protein from the trans
side of the membrane. Interestingly, prokaryotic (P-type) and
endoplasmic reticular (ER-type) SPases are functionally equivalent, but
structurally quite different, forming two distinct SPase families that
share only few conserved residues. P-type SPases were, so far,
exclusively identified in eubacteria and organelles, whereas ER-type
SPases were found in the three kingdoms of life. Strikingly, the
presence of ER-type SPases appears to be limited to sporulating
Gram-positive eubacteria. The present studies were aimed at the
identification of potential active site residues of the ER-type SPase
SipW of Bacillus subtilis, which is required for processing
of the spore-associated protein TasA. Conserved serine, histidine, and
aspartic acid residues are critical for SipW activity, suggesting that
the ER-type SPases employ a Ser-His-Asp catalytic triad or,
alternatively, a Ser-His catalytic dyad. In contrast, the P-type SPases
employ a Ser-Lys catalytic dyad (Paetzel, M., Dalbey, R. E., and
Strynadka, N. C. J. (1998) Nature 396, 186-190).
Notably, catalytic activity of SipW was not only essential for pre-TasA
processing, but also for the incorporation of mature TasA into spores.
In recent years, interesting similarities between the process of
protein transport across the bacterial plasma membrane and the
eukaryotic endoplasmic reticular
(ER)1 membrane have been
documented. These similarities include the direction of protein
transport (i.e. export from the cytoplasm), the targeting
signal (i.e. the signal peptide), the signal recognition particle, components of the translocation channel, signal peptidases (SPases), and thiol-disulfide oxidoreductases (for reviews, see Refs.
1-4). Notwithstanding these similarities, significant differences between protein transport across bacterial plasma membranes and the ER
membrane do exist. First, protein transport is energized in different
ways. Although bacterial protein export requires a cytosolic
force-generator (i.e. SecA), and the proton-motive-force (5-7), protein import into the ER lumen is driven by the ribosome (co-translational protein transport; Refs. 8-10), or the lumenal Kar2
protein (post-translational protein transport in yeast; Refs. 11 and
12). Second, as exemplified by the SPases, the similarities between
components of the different protein transport machineries are rather
weak (see Refs. 1 and 2).
Homologous SPases have been identified in Gram-positive and
Gram-negative eubacteria, the inner membrane of yeast mitochondria, the
thylakoid membrane of chloroplasts, archaea, and the ER membranes of
yeast and higher eukaryotes, such as Homo sapiens (Ref. 1; see Fig. 1). These enzymes, which remove signal peptides from translocated proteins, are required for the release of the mature protein from the trans side of the membrane (for reviews,
see Refs. 1 and 13). We have previously shown that SPases can be
divided into two distinct subfamilies, denoted P- and ER-type SPases.
P-type SPases were exclusively identified in eubacteria, mitochondria,
and chloroplasts, whereas ER-type SPases were identified in eukaryotes,
archaea, and four sporulating Gram-positive eubacteria, Bacillus
subtilis, Bacillus amyloliquefaciens, Bacillus
anthracis, and Clostridium perfringens (Ref. 14; see
Fig. 1). Recent studies have provided strong evidence that the P-type
SPases employ a Ser-Lys catalytic dyad (1, 15) In contrast, the
catalytic mechanism of the ER-type SPases remains to be
elucidated (16).
The observation that B. subtilis contained an ER-type SPase,
denoted SipW, was remarkable for two reasons. First, SipW represented the first ER-type SPase identified in a eubacterium. Second, SipW happened to be the fifth chromosomally encoded SPase of B. subtilis (14). In contrast to SipW, the other four SPases of
B. subtilis, denoted SipS, SipT, SipU, and SipV, are of the
P-type (14, 17, 18). Notably, SipU, SipV, and SipW are of minor
importance for the processing of secretory pre-proteins, in contrast to
SipS and SipT, which are critical for protein secretion and viability (14, 19). This suggested that SipU, SipV, and SipW might be required
for the processing of a specific subset of the approximately 180 predicted pre-proteins of B. subtilis. The latter hypothesis was recently confirmed for SipW, which was shown to be required for the
processing of the spore-associated protein TasA, displaying antibacterial activities (20). Consistent with a role in sporulation, the expression of the tasA gene (previously known as
cotN; Ref. 14), which is located immediately downstream of
the sipW gene, depended on the post-exponential growth
phase-specific transcription factors SpoOA and SpoOH (20, 21).
Interestingly, TasA was not only incorporated into spores, but also
secreted into the growth medium. Similar to TasA, the YqxM pre-protein,
which is specified by a gene that is located immediately upstream of
the sipW gene, was also processed and secreted in a
SipW-dependent manner. In contrast to TasA, mature YqxM was
not incorporated into spores (22).
The present studies were aimed at the identification of potential
active site residues of SipW. For this purpose, TasA was an ideal
reporter because its processing is strongly dependent on the presence
of the SipW protein (20, 23). Furthermore, in contrast to YqxM, the
precursor and mature forms of TasA can be readily detected in
sporulating cells of B. subtilis. Finally, TasA could be
used to study the importance of processing by SipW for the
incorporation of this protein into spores, as neither TasA nor SipW is
required for the sporulation process per se. The results
show that conserved Ser, His, and Asp residues are critical for the
activity of SipW, and that catalytically active SipW is required for
the incorporation of mature TasA into spores.
Plasmids, Bacterial Strains, and Media--
Table
I lists the plasmids and bacterial
strains used. Tryptone/yeast extract (TY medium) contained
Bacto-tryptone (1%), Bacto-yeast extract (0.5%), and NaCl (1%).
Minimal medium for B. subtilis was prepared as described by
Tjalsma et al. (14). When required, medium for
Escherichia coli was supplemented with kanamycin (40 µg/ml); media for B. subtilis were supplemented with
kanamycin (10 µg/ml), neomycin (3.5 µg/ml), or chloramphenicol (5 µg/ml).
DNA Techniques--
Procedures for DNA purification,
restriction, ligation, agarose gel electrophoresis, and transformation
of E. coli were carried out as described by Sambrook
et al. (28). Enzymes were from Roche Molecular Biochemicals.
B. subtilis was transformed as described by Tjalsma et
al. (14). PCR was carried out with Pwo DNA
polymerase (Roche Molecular Biochemicals) as described by van
Dijl et al. (29). The BLAST algorithm (30) was used
for protein comparisons in GenBankTM.
To construct plasmid pGDL140, carrying the wild-type sipW
gene, a PCR with the primers lbw-1 and lbw-2 (Table
II) was performed using chromosomal
B. subtilis 168 DNA as a template. The amplified fragment
was subsequently cleaved with SalI and EcoRI, and
ligated into the corresponding sites of pGDL48 (24) in such a way that sipW transcription is driven by the constitutive
erythromycin promoter. Site-directed mutations were introduced into
plasmid-borne copies of sipW by a two-step PCR approach
(29), using lbw-1, lbw-2, and the mutagenic oligonucleotides shown in
Table II. Amplified fragments were cleaved with SalI and
EcoRI, and ligated into the corresponding sites of pGDL48.
The resulting plasmids were named pW-x, where x indicates the position
and type of amino acid substitution in the corresponding SipW mutant
protein.
Fractionation of Sporulating Cells and Trypsin Accessibility
Assays--
Protoplasts were prepared from sporulating cells of
B. subtilis. To this purpose, cells were resuspended in
protoplast buffer (20 mM potassium phosphate, pH 7.5, 15 mM MgCl2, 20% sucrose) and incubated for 30 min in the presence of 0.5 mg/ml lysozyme (37 °C). Next, the
protoplasts were collected by centrifugation and resuspended in fresh
protoplast buffer. If desired, the protoplast-supernatant, which
contains cell wall-associated proteins, was collected and used for
SDS-PAGE and Western blotting. The protease accessibility of
(membrane-associated) proteins was tested by incubating the protoplasts
at 37 °C in the presence of 1 mg/ml trypsin (Sigma) for 30 min. In
parallel, protoplasts were incubated without trypsin, or in the
presence of trypsin and 1% Triton X-100. To isolate endospores,
protoplasts were lysed by incubation for 5 min in protoplast buffer
containing 1% Triton X-100. To release proteins from the spore
envelope, spores were collected by centrifugation, resuspended in
protoplast buffer, and incubated for 30 min in the presence of 1 mg/ml
lysozyme (37 °C). Next, the samples were incubated at 37 °C in
the presence of 1 mg/ml trypsin (Sigma) and 1% Triton X-100 for 30 min
to test the protease sensitivity of spore-associated proteins. All
trypsin digestions were terminated by the addition of 1.2 mg/ml
trypsin inhibitor (Sigma), before boiling in loading buffer for
SDS-PAGE.
Western Blot Analysis and Immunodetection--
To obtain
SipW-specific antibodies, the pET32a plasmid (Novagen) was used to fuse
part of SipW (residues 25-133; lacking its putative membrane anchors)
to a thioredoxin fragment containing a hexahistidine tag. The fusion
protein was expressed in E. coli, and purified by metal
affinity chromatography using the Talon resin supplied by
CLONTECH. Rabbits were immunized with the fusion protein at Eurogentec.
Western blotting was performed as described by Kyhse-Andersen (31).
Samples for SDS-PAGE were prepared as described by van Dijl et
al. (32). After separation by SDS-PAGE, proteins were transferred
to Immobilon PVDF membranes (Millipore Corp.). (Pre-)TasA, SipW, GroEL,
Identification of Conserved Residues in ER-type SPases of
Eukaryotes, Archaea, and Eubacteria--
Thus far, genes for 19 different ER-type SPases have been identified in Gram-positive
eubacteria, archaea, and eukaryotes. This allowed a detailed comparison
of the deduced amino acid sequences of these enzymes (Fig.
1), which showed that they consist of a highly conserved amino-terminal moiety (Fig.
2A, indicated with ER-C) and a highly variable carboxyl-terminal moiety (Fig.
2A, indicated with ER-V). In some enzymes, the
variable moiety contains one or three putative membrane spanning
domains (Fig. 2B). The highly conserved moiety contains one
amino-terminal membrane anchor (A) and four conserved
domains (B-E), which are present in all known P- and
ER-type SPases (Fig. 1; see Refs. 1 and 14). Domain B contains the
conserved serine residue, which has been shown to be critical for the
activity of P-type SPases from E. coli (15, 44), B. subtilis (29), and mitochondria (45). Streches of conserved amino
acids resembling domain C of the P-type SPases, which seems to be
involved in substrate binding (15) and catalysis (46), can be found
twice in ER-type SPases (Fig. 1, domain C and
C'). Domain D of the ER-type SPases contains a strictly
conserved histidine residue, replacing the strictly conserved lysine
residue in domain D of the P-type SPases. Finally, domain E contains
two conserved aspartic acid residues, the equivalents of which are
involved in salt bridge formation in the P-type SPases (15, 47). Recent
observations indicate that these salt bridges are important
determinants for the stability of some P-type SPases, such as SipS of
B. subtilis (29, 46). Interestingly, domain E of the Sec11
protein of Archeoglobus fulgidus seems to be duplicated (Fig. 1). Taken together, these observations suggest that the conserved
residues in domains B-E are required for the catalytic activity and/or
stability of the ER-type SPases.
Identification of the Potential Active Site of SipW--
To
investigate whether the conserved residues of domains A-E of the
ER-type SPases are required for the activity of SipW of B. subtilis, we exploited the recent observation that SipW is of
major importance for processing of the spore-associated protein TasA
(20). To this purpose, a plasmid-based complementation system was
developed, involving B. subtilis strain
To investigate the importance for pre-TasA processing of conserved
residues in domains B-E of SipW, the residues Ser-47, His-87, Arg-88,
Lys-104, Asp-106, or Asp-112 were replaced by alanine (see Fig. 1; note
that the latter residue numbers correspond to the sequence of SipW of
B. subtilis (Bsu)). Alanine was chosen because it
is small, and has a chemically inert side chain, minimizing conformational strain and indirect effects on catalysis. To monitor pre-TasA processing by the various SipW mutant proteins, B. subtilis
Unexpectedly, only the completely inactive SipW-S47A and -H87A mutant
proteins reacted (weakly) with a SipW-specific antibody, whereas
neither wild-type SipW nor the active SipW mutant proteins, including SipW-D106A, were detectable (Fig. 3C,
upper panel). This weak interaction, or the
complete absence of reactivity between SipW (mutant proteins) and
SipW-specific antibodies was not due to a loss of
sipW-containing plasmids, as shown by the detection of
comparable amounts of the plasmid-encoded Catalytic Activity of SipW Is Required for TasA Incorporation into
Spores--
To investigate the importance of SipW for TasA
incorporation into spores, fractionation experiments were performed
(schematically presented in Fig.
4A), in which the cytosolic
GroEL protein was used as a reference marker for protoplast integrity
and, upon permeabilization of membranes with Triton X-100, trypsin
activity. As shown with B. subtilis
To verify whether the above fractionation experiments truly reflected
the situation in sporulating cells that are wild-type with respect to
the temporally controlled synthesis of TasA and SipW, similar
fractionation experiments were performed with B. subtilis
PM8. This strain offers the advantage that it produces the E. coli
To determine whether active SipW is required for the sorting of TasA to
spores, fractionation experiments were performed with B. subtilis
In summary, these observations show that active SipW is required for
the incorporation of mature TasA into spores, but not for the
accumulation of mature TasA in the cell wall of sporulating cells.
In the present studies, we document the importance of SipW for
processing of pre-TasA and incorporation of mature TasA into spores.
Translocated pre-TasA was almost exclusively processed by SipW, a
process that requires three conserved residues (i.e. Ser-47,
His-87, and Asp-106) of this SPase. In sporulating cells lacking active
SipW, TasA did not reach the spores. Instead, TasA precursors were
translocated across and remained attached to the cytoplasmic membrane,
most likely with their uncleaved signal peptides. Upon prolonged growth
in the absence of SipW, pre-TasA was processed by other, yet
unidentified, SPases of B. subtilis. Most likely, this
alternative pre-TasA processing is a result of the combined activities
of SipS, SipT, SipU, and/or SipV, as the SPases of B. subtilis, including SipW, have overlapping substrate specificities
(14, 18). Strikingly, mature TasA produced by alternative processing in
the absence of SipW did not reach the spores, but remained associated
with the cell wall. This shows that the presence of SipW is a
prerequisite for the incorporation of mature TasA into spores.
Interestingly, this process requires active SipW and cannot be promoted
by catalytically inactive SipW molecules. It is presently not clear how
SipW functions as a determinant for the incorporation of TasA into
spores, or why alternatively processed mature TasA is not incorporated
into spores.
As recently confirmed by the crystal structure of a catalytically
active soluble fragment of the E. coli SPase I (15), also known as leader peptidase, P-type SPases employ a Ser-Lys catalytic dyad, similar to LexA-like proteases (29, 45, 50-52). The observations that the catalytic serine residue of the P-type SPases is well conserved in the ER-type SPases, and that this conserved serine residue
(Ser-47) is essential for the activity of SipW, indicate that the
ER-type SPases employ a serine residue for catalysis. Notably, the
ER-type SPases contain a strictly conserved histidine residue instead
of the catalytic lysine residue of the P-type SPases (17, 53). This
conserved histidine residue (His-87) is essential for activity of SipW.
Taken together, these findings suggest that Ser-47 of SipW acts as a
nucleophile that attacks the carbonyl carbon of the scissile peptide
bond, whereas His-87 acts as a general base by stripping the proton
from the hydroxyl group of the serine side chain. A similar role has
been proposed for the corresponding serine and histidine residues of
Sec11p from yeast (16). The role of the strictly conserved Asp-106 residue of SipW, which is important, but not essential, for activity, is less clear. First, by analogy to the classical serine proteases, Asp-106 could form a catalytic triad together with Ser-47 and His-87,
thereby serving to keep the side chain of His-87 deprotonated. Second,
Asp-106 could be a determinant for the stability of SipW, as described
previously for Asp-146 of SipS of B. subtilis (14, 29) and
Asp-103 of Sec11p (16). The latter hypothesis is supported by the
observation that both aspartic acid residues are present at equivalent
positions in the conserved domain E of P- and ER-type SPases.
Furthermore, the recent observation that the equivalent Asp residue in
domain E of the SPase I of E. coli is not required for
activity (49) suggests that this conserved Asp residue has a structural
rather than a catalytic function. Thus, it is possible that ER-type
SPases, such as SipW, employ a Ser-His catalytic dyad, instead of the
Ser-His-Asp catalytic triad of the classical serine proteases. The
latter view is strongly supported by the observation that the potential
active site His-47 residue of SipW can be replaced by lysine without
loss of pre-TasA processing activity. This implies that the catalytic
mechanisms of P-type SPases and ER-type SPases are, at least to some
extent, related.
We thank Drs. A. Bolhuis, J. D. H. Jongbloed, M. L. van Roosmalen, and other members of the European
Bacillus Secretion Group for useful discussions.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by Genencor International (Rijswijk, The Netherlands) and
Gist-brocades B.V. (Delft, The Netherlands).
**
Supported in part by a Schmitt fellowship.
§§
To whom correspondence should be addressed. Present address:
Dept. of Pharmaceutical Biology, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. Tel.:
31-503633079; Fax: 31-503632348; E-mail:
j.m.van.dijl@farm.rug.nl.
Published, JBC Papers in Press, May 24, 2000, DOI 10.1074/jbc.M002676200
The abbreviations used are:
ER, endoplasmic
reticular;
SPase, signal peptidase;
PAGE, polyacrylamide gel
electrophoresis;
PCR, polymerase chain reaction;
TY, tryptone/yeast
extract;
P-type, prokaryotic.
Conserved Serine and Histidine Residues Are Critical for
Activity of the ER-type Signal Peptidase SipW of Bacillus
subtilis*
§,
**,
,
,

, and

§§
Department of Genetics, Groningen
Biomolecular Sciences and Biotechnology Institute, Kerklaan 30, 9751 NN Haren, The Netherlands and the ¶ Department of
Microbiology and Immunology, Loyola University Medical Center,
Maywood, Illinois 60153
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Plasmids and bacterial strains
Oligonucleotides used for sipW mutagenesis
-lactamase, or SspB-LacZ, were visualized with specific antibodies
and horseradish peroxidase anti-rabbit-IgG conjugates (Amersham
Pharmacia Biotech).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (55K):
[in a new window]
Fig. 1.
Conserved domains B-E in ER-type SPases from
eubacteria, archaea, and eukaryotes. The comparison includes the
amino acid sequences of ER-type SPases from the Gram-positive
eubacteria B. subtilis (SipW (Bsu); Ref. 14),
B. amyloliquefaciens (SipW (Bam); GenBankTM
accession no. AF085497), B. anthracis (SipW
(Ban)), and C. perfringens (Spc21
(Cpe); GenBankTM accession no. X86488); the archaea: A. fulgidus (Spc21 (Afu), Sec11 (Afu),
Sip1 (Afu), and Sip2 (Afu); GenBankTM loci
AF1657, AF1791, AF1655, and AF2078, respectively; Ref. 33),
Methanobacterium thermoautotrophicum (Sip (Mth);
GenBankTM locus MTH1448; Ref. 34), Methanococcus jannaschii
(Sip (Mja), GenBankTM locus MJU67481; Ref. 35), and
Pyrococcus horikoshii (Spc (Pho) and Sip
(Pho); GenBankTM loci PH0590 and PH0563, respectively; Ref. 36);
and the eukaryotes: Saccharomyces cerevisiae (Sec11p
(Sce); Ref. 37), Schizosaccharomyces pombe
(Sec11p (Spo); GenBankTM accession no. E1313476),
Caenorhabditis elegans (Spc18 (Cel);
Ref. 38), Canis familiaris (Spc18
(Cfa) and Spc21 (Cfa); Refs. 39 and
40), Rattus norvegicus (Spc18 (Rno);
Ref. 41), and H. sapiens (Spc18 (Hsa);
GenBankTM accession no. G3641344). Residues are printed in
bold when present in at least 10 of the 19 ER-type SPases.
Numbers refer to the position of the first amino acid of
each boxed region (B-E) in the respective
SPases. In the consensus sequence below each domain,
uppercase letters indicate residues that are
strictly conserved in all known ER-type SPases, and
lowercase letters show identity in at least 10 sequences. A number sign (#) indicates conserved hydrophobic residues,
and + indicates conserved positively charged residues. Note that domain
C is duplicated in the ER-type SPases. Conserved residues of B. subtilis SipW (SipW (Bsu)), which, through
site-specific mutagenesis, are replaced by alanine (A) or
lysine (K), are indicated below the
boxed regions. Residues required for activity (
) of SipW
are indicated above the boxed regions. The
consensus sequence of the domains B-E of the P-type SPases, is
indicated as described by Dalbey et al. (1).

View larger version (34K):
[in a new window]
Fig. 2.
Conserved and variable regions in ER-type
SPases. A, ER-type SPases consist of a well conserved
amino-terminal moiety (ER-C) and a variable
carboxyl-terminal moiety (ER-V). The amino-terminal moiety
comprises a membrane anchor (A) and the highly conserved
domains (B-E). Five different types of variable
carboxyl-terminal moieties (ER-V) can be identified in the
known ER-type SPases, four of which contain either one or three
(putative) membrane anchors (indicated with a black
box), as predicted with algorithms developed by Sipos and
von Heijne (42). Conserved stretches of amino acids in the ER-V
moieties are indicated with patterned boxes.
B, comparison of the predicted membrane topologies of the
ER-type SPases. The orientation of putative transmembrane
segments, A(nchor) I-A(nchor) IV, was predicted by the TopPred2
algorithm (42, 43). Domains B-E in the highly conserved amino-terminal
moiety are indicated. The highly variable carboxyl-terminal moiety,
which may contain one or three transmembrane segments, is indicated
with a dotted line. N, amino terminus;
C, carboxyl terminus; in, cytoplasmic side of the
membrane; out, extracytoplasmic, cell wall-exposed side of
the membrane (eubacteria and archaea), or the ER lumen
(eukaryotes).
W-CtasA, which lacks SipW ("
W") and constitutively
produces pre-TasA ("CtasA"). First, B. subtilis
W-CtasA was transformed with pGDL140
("SipW"; constitutive expression of sipW), pGDL41
("SipS"; 5-fold overproduction of SipS in the stationary growth
phase; data not shown), or pGDL48 ("empty vector"; no SPase
overproduction). Next, the effects on the processing of pre-TasA to the
mature form were evaluated by growing the resulting strains in TY
medium, sampling after 4, 16, and 32 h of post-exponential growth,
and Western blotting of total cell and sporangial lysates. The results
show that after 4 h of post-exponential growth (t = 4), only pre-TasA was present in cells of B. subtilis
W-CtasA, irrespective of the (over)production of SipS or
SipW (Fig. 3A). The
observation that the presence of multiple copies of sipW did
not stimulate pre-TasA processing at t = 4 suggests
that SipW requires an as yet unidentified partner protein that is not
(yet) expressed at this time. In contrast, after 16 h of
post-exponential growth (t = 16), B. subtilis
W-CtasA cells producing SipW contained both
the precursor and mature forms of TasA, whereas no mature TasA
was observed in B. subtilis
W-CtasA cells lacking SipW (Fig. 3A). Finally, after
32 h (t = 32), most TasA molecules in B. subtilis
W-CtasA cells producing SipW were mature.
In contrast, significantly lower amounts of mature TasA were detectable
in B. subtilis
W-CtasA cells lacking SipW
(Fig. 3A). The SipW-independent processing of pre-TasA at
t = 32 was not affected by SipS overproduction,
suggesting that one or more other SPases are responsible for this
effect. As no SipW-independent processing of pre-TasA was observed at
t = 16, this time point was selected to monitor the
activity of SipW proteins with site-specific mutations.

View larger version (40K):
[in a new window]
Fig. 3.
SipW-dependent processing of
pre-TasA. A, pre-TasA processing in B. subtilis
W-CtasA, transformed with pGDL140 (SipW),
pGDL41 (approximately 5-fold overproduction of SipS; data not shown),
or pGDL48 (empty vector) was analyzed by SDS-PAGE, Western blotting,
and immunodetection with TasA-specific antibodies. Upon 4, 16, and
32 h of post-exponential growth in TY medium, cells were collected
by centrifugation and used for SDS-PAGE (zero time (t = 0) defines the transition point between the exponential and
post-exponential growth phases). The positions of precursor
(p) and mature (m) forms of TasA are indicated.
B, pre-TasA processing by SipW mutant proteins. B. subtilis
W-CtasA was transformed with plasmids
pW-S47A, pW-H87A, pW-R88A, pW-K104A, pW-D106A, or pW-D112A, all of
which specify a SipW mutant protein. Pre-TasA processing in these
strains, and B. subtilis
W-CtasA harboring
pGDL140 (SipW; positive control), or pGDL41 (SipS; negative control),
was monitored after 16 h of post-exponential growth in TY medium
as described in panel A of this figure.
C, the integrity of SipW mutant proteins with strongly
reduced activity was analyzed by SDS-PAGE, Western blotting, and
immunodetection with SipW-specific antibodies. Samples were taken of
B. subtilis
W-CtasA cells harboring the
plasmids pW-S47A, pW-H87A, pW-D106A, pGDL140 (SipW), or pGDL41 (SipS;
negative control) after 16 h of post-exponential growth in TY
medium. The presence of sipW-containing plasmids, which also
contain a gene encoding
-lactamase, was monitored with
-lactamase-specific antibodies. The positions of SipW-specific and
-lactamase-specific (Bla) bands are indicated.
D, pre-TasA processing by SipW-H87K was analyzed by using
B. subtilis
W-CtasA transformed with the
plasmids pW-H87K, or pW-H87A (negative control) as described in
panel B of this figure.
W-CtasA was transformed with plasmids
encoding wild-type SipW (positive control), the SipW mutant proteins
S47A, H87A, R88A, K104A, D106A, or D112A, or SipS (negative control).
The resulting strains were grown in TY medium until t = 16. As demonstrated by Western blotting, more than 50% of the TasA
molecules in cells producing SipW-R88A, -K104A, or -D112A was in the
mature form, similar to cells producing wild-type SipW (Fig.
3B), showing that Arg-88, Lys-104, and Asp-112 are not
important for pre-TasA processing. In contrast, very low amounts of
mature TasA were detectable in cells producing SipW-D106A. No mature
TasA was detectable in cells producing SipW-S47A or -H87A, as in
SipS-producing cells. These results show that the conserved serine and
histidine residues of SipW are critical for the processing of pre-TasA,
and that Asp-106 is very important for this activity. Notably, the
conserved His-87 of SipW could be replaced by lysine without loss of
pre-TasA processing (Fig. 3D), suggesting that a basic
residue at this position is required for activity of SipW.
-lactamase in all samples
(Fig. 3C, lower panel). The latter
observations suggest that the catalytically active forms of SipW are
subject to self-cleavage, as described previously for the purified
SPase of E. coli (49). In summary, these results suggest
that Ser-47 and His-87 are involved in catalysis, and that Asp-106 is
either involved in catalysis or in maintaining a stable conformation.
W-CtasA
(pGDL140), at t = 32, TasA has a dual localization in
sporulating cells producing SipW. First, a significant fraction of the
mature TasA could be released from these cells by protoplasting,
showing that these molecules were present in the cell wall (Fig.
4B). Second, pre-TasA remained protoplast-associated, but
was degraded when trypsin was added to the protoplasts, showing that
this form of TasA accumulated at the membrane-cell wall interface.
Third, significant amounts of mature TasA remained associated with the
protoplasts in a trypsin-resistant form. The latter TasA molecules were
not degraded by trypsin when the protoplasts were lysed with Triton
X-100. In fact, these molecules were associated with spores, and they
only became accessible to trypsin upon incubation of isolated
spores with lysozyme and Triton X-100 (Fig. 4A; note
that lysozyme and Triton X-100 were sufficient to cause spore lysis due
to the absence of a spore coat in B. subtilis
W-CtasA). In contrast, all mature TasA produced by
B. subtilis
W-CtasA (pGDL41), which lacks
SipW, was released from the sporulating cells by protoplasting, showing
that it was localized in the cell wall of the mother cell and not in
spores (Fig. 4C). Similar to SipW-producing cells, the
pre-TasA molecules accumulating in cells lacking SipW were
protoplast-associated and, upon protoplasting, accessible to trypsin,
indicating that they were localized at the membrane-cell wall interface
of the mother cell. In addition, a specific 29-kDa degradation product
of TasA (d), which accumulates in the absence of SipW, was
localized at the membrane-cell wall interface.

View larger version (30K):
[in a new window]
Fig. 4.
SipW is essential for incorporation of mature
TasA into spores. To determine the localization of precursor and
mature forms of TasA in sporulating cells of B. subtilis,
fractionation experiments were performed as schematically presented in
panel A. The cell wall (w) is
indicated in gray shading. Solid
lines indicate intact membranes, and dotted
lines indicate membranes disrupted with Triton X-100. Note
that endospores are initially surrounded by two membranes (see Ref.
48). C, intact cell; PP, protoplast;
SP, spore; T, trypsin. B-D, cells of
B. subtilis
W-CtasA harboring the plasmids
pGDL140 (SipW; panel B) or pGDL41 (no SipW;
panel C), or cells of B. subtilis PM8
(SspB-LacZ; panel D) were grown in TY medium
until 32 h after the transition between exponential and
post-exponential growth. Next, cells (c) were protoplasted,
and protoplasts (pp) were separated from the cell wall
(w) fraction (i.e. protoplast supernatant) by
centrifugation. Complete cells, protoplasts, and the cell wall fraction
were used for SDS-PAGE, Western blotting, and immunodetection with
TasA-, GroEL-, or LacZ-specific antibodies. In addition, protoplasts
were incubated for 30 min in the presence of trypsin (1 mg/ml), or
trypsin plus Triton X-100 (1%). Finally, endospores (sp)
were isolated from the lysed cells to investigate whether
spore-associated TasA was trypsin resistant per se, or
protected against trypsin by the spore envelope. Spores were incubated
with lysozyme prior to the addition of trypsin plus Triton X-100.
Intact and lysed spores were used for SDS-PAGE and Western blotting.
The positions of GroEL (cytosolic marker), SspB-LacZ (spore-specific
marker), and pre-TasA (p), mature TasA (m), and a
degradation (d) product of TasA are indicated.
-galactosidase (LacZ) exclusively in the forespore (26,
27). Thus, the fractionation of spore-associated proteins can be
monitored with antibodies against LacZ. This was not possible with
antibodies against GroEL as this protein appears to be absent from
spores (Fig. 4, B and C). As shown in Fig.
4D, B. subtilis PM8 showed similar fractionation
patterns for TasA and GroEL as B. subtilis
W-CtasA (pGDL140) (Fig. 4B).
Furthermore, LacZ cofractionated with spores. Notably, a significant
fraction of the LacZ molecules appeared to be trypsin-sensitive upon
protoplast lysis, indicating that the spores were not yet mature.
W-CtasA producing SipW mutant proteins. As
shown in Fig. 5, trypsin-resistant mature
TasA was absent from protoplasts of B. subtilis
W-CtasA producing the S47A or H87A SipW mutant proteins.
In contrast, trypsin-resistant mature TasA was present in protoplasts
of B. subtilis
W-CtasA producing the H87K,
R88A, K104A, D106A, or D112A SipW mutant proteins, or wild-type SipW. Irrespective of the presence of active or inactive mutant SipW proteins, the pre-TasA accumulating in protoplasts of B. subtilis
W-CtasA was accessible to trypsin (Fig.
5).

View larger version (70K):
[in a new window]
Fig. 5.
Catalytically active SipW is required for
TasA incorporation into spores. To determine the localization of
precursor and mature forms of TasA in sporulating cells carrying mutant
SipW proteins, B. subtilis
W-CtasA harboring
the plasmids pW-S47A, pW-H87A, pW-R88A, pW-K104A, pWD106A, pW-D112A,
pGDL41 (no SipW; negative control), or pGDL140 (SipW; positive control)
were grown in TY medium for 32 h after the transition between
exponential and post-exponential growth. Subsequently, cells were
protoplasted and incubated for 30 min without further additions, in the
presence of trypsin (1 mg/ml), or in the presence of trypsin plus
Triton X-100 (1%). Samples were used for SDS-PAGE, Western blotting,
and immunodetection with TasA- and GroEL-specific antibodies
(cytoplasmic control). The positions of pre-TasA (p), mature
TasA (m), and GroEL are indicated.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Supported by Public Health Service Grant GM539898 from the
National Institutes of Health and a grant from the Schweppe Foundation.

Supported by Biotechnology Grants Bio4-CT95-0278 and
Bio4-CT96-0097 and "Quality of Life and Management of Living
Resources" Grants QLK3-CT-1999-00415 and QLK3-CT-1999-00917 from the
European Union.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Dalbey, R. E.,
Lively, M. O.,
Bron, S.,
and van Dijl, J. M.
(1997)
Protein Sci.
6,
1129-1138
2.
Pohlschröder, M.,
Prinz, W. A.,
Hartmann, E.,
and Beckwith, J.
(1997)
Cell
91,
563-566
3.
von Heijne, G.
(1990)
Curr. Opin. Cell Biol.
2,
604-608
4.
von Heijne, G.
(1998)
Nature
396,
111, 113
5.
den Blaauwen, T.,
and Driessen, A. J. M.
(1996)
Arch. Microbiol.
165,
1-8
6.
Wickner, W.,
and Leonard, M. R.
(1996)
J. Biol. Chem.
271,
29514-29516
7.
Economou, A.
(1998)
Mol. Microbiol.
27,
511-518
8.
Görlich, D.,
and Rapoport, T. A.
(1993)
Cell
75,
615-630
9.
Crowley, K. S.,
Liao, S.,
Worrell, V. E.,
Reinhart, G. D.,
and Johnson, A. E.
(1994)
Cell
78,
461-471
10.
Riezman, H.
(1997)
Science
278,
1728-1729
11.
Brodsky, J. L.,
Goeckeler, J.,
and Schekman, R. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9643-9646
12.
Panzner, S.,
Dreier, L.,
Hartmann, E.,
Kostka, S.,
and Rapoport, T. A.
(1995)
Cell
81,
561-570
13.
Pugsley, A. P.
(1993)
Microbiol. Rev.
57,
50-108
14.
Tjalsma, H.,
Bolhuis, A.,
van Roosmalen, M. L.,
Wiegert, T.,
Schumann, W.,
Broekhuizen, C. P.,
Quax, W. J.,
Venema, G.,
Bron, S.,
and van Dijl, J. M.
(1998)
Genes Dev.
12,
2318-2331
15.
Paetzel, M.,
Dalbey, R. E.,
and Strynadka, N. C. J.
(1998)
Nature
396,
186-190
16.
VanValkenburg, C.,
Xuemin, C.,
Mullins, C.,
Fang, H.,
and Green, N.
(1999)
J. Biol. Chem.
274,
11519-11525
17.
van Dijl, J. M.,
de Jong, A.,
Vehmaanper, J.,
Venema, G.,
and Bron, S.
(1992)
EMBO J.
11,
2819-2828
18.
Tjalsma, H.,
Noback, M. A.,
Bron, S.,
Venema, G.,
Yamane, K.,
and van Dijl, J. M.
(1997)
J. Biol. Chem.
272,
25983-25992
19.
Tjalsma, H.,
van den Dolder, J.,
Meijer, W. J. J.,
Venema, G.,
Bron, S.,
and van Dijl, J. M.
(1999)
J. Bacteriol.
181,
2448-2454
20.
Stöver, A. G.,
and Driks, A.
(1999)
J. Bacteriol.
181,
1664-1672
21.
Stöver, A. G.,
and Driks, A.
(1999)
J. Bacteriol.
181,
5476-5481
22.
Stöver, A. G.,
and Driks, A.
(1999)
J. Bacteriol.
181,
7065-7069
23.
Serrano, M.,
Zilhao, R.,
Ricca, E.,
Ozin, A. J.,
Moran, C. P., Jr.,
and Henriques, A. O.
(1999)
J. Bacteriol.
181,
3632-3643
24.
Meijer, W. J. J.,
de Jong, A.,
Wisman, G. B. A.,
Tjalsma, H.,
Venema, G.,
Bron, S.,
and van Dijl, J. M.
(1995)
Mol. Microbiol.
17,
621-631
25.
Wertman, K. F.,
Wyman, A. R.,
and Botstein, D.
(1986)
Gene (Amst.)
49,
253-262
26.
Mason, J. M.,
Hackett, R. H.,
and Setlow, P.
(1988)
J. Bacteriol.
170,
239-244
27.
Margolis, P.,
Driks, A.,
and Losick, R.
(1991)
Science
254,
562-565
28.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29.
van Dijl, J. M.,
de Jong, A.,
Venema, G.,
and Bron, S.
(1995)
J. Biol. Chem.
270,
3611-3618
30.
Altschul, S. F.,
Madden, T. L.,
Schaffer, A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402
31.
Kyhse-Andersen, J.
(1984)
J. Biochem. Biophys. Methods
10,
203-209
32.
van Dijl, J. M.,
de Jong, A.,
Smith, H.,
Bron, S.,
and Venema, G.
(1991)
Mol. Gen. Genet.
227,
40-48
33.
Klenk, H. P.,
Clayton, R. A.,
Tomb, J. F.,
White, O.,
Nelson, K. E.,
Ketchum, K. A.,
Dodson, R. J.,
Gwinn, M.,
Hickey, E. K.,
Peterson, J. D.,
Richardson, D. L.,
et al..
(1997)
Nature
390,
364-370
34.
Smith, D. R.,
Doucette-Stamm, L. A,
Deloughery, C.,
Lee, H.,
Dubois, J.,
Aldredge, T.,
Bashirzadeh, R.,
Blakely, D.,
Cook, R.,
Gilbert, K.,
et al..
(1997)
J. Bacteriol.
179,
7135-7155
35.
Bult, C. J.,
White, O.,
Olsen, G. J.,
Zhou, L.,
Fleischmann, R. D.,
Sutton, G. G.,
Blake, J. A.,
FitzGerald, L. M.,
Clayton, R. A.,
Gocayne, J. D.,
Kerlavage, A. R.,
Dougherty, B. A.,
Tomb, J. F.,
Adams, M. D.,
Reich, C. I.,
Overbeek, R.,
Kirkness, E. F.,
Weinstock, K. G.,
Merrick, J. M.,
Glodek, A.,
Scott, J. L.,
Geoghagen, N. S. M.,
and Venter, J. C.
(1996)
Science
273,
1058-1073
36.
Kawarabayasi, Y.,
Sawada, M.,
Horikawa, H.,
Haikawa, Y.,
Hino, Y.,
Yamamoto, S.,
Sekine, M.,
Baba, S.,
Kosugi, H.,
Hosoyama, A.,
Nagai, Y.,
Sakai, M.,
Ogura, K.,
Otsuka, R.,
Nakazawa, H.,
Takamiya, M.,
Ohfuku, Y.,
Funahashi, T.,
Tanaka, T.,
Kudoh, Y.,
Yamazaki, J.,
Kushida, N.,
Oguchi, A.,
Aoki, K.,
and Kikuchi, H.
(1998)
DNA Res.
5,
147-155
37.
Böhni, P. C.,
Deshaies, R. J.,
and Schekman, R. W.
(1988)
J. Cell Biol.
106,
1035-1042
38.
The C. elegans Sequencing Consortium.
(1998)
Science
282,
2012-2018
39.
Shelness, G. S.,
Lin, L.,
and Nicchitta, C. V.
(1993)
J. Biol. Chem.
268,
5201-5208
40.
Greenburg, G.,
Shelness, G. S.,
and Blobel, G.
(1989)
J. Biol. Chem.
264,
15762-15765
41.
Signs, S. A.,
and Jacquet, R.
(1994)
Mol. Cell. Biochem.
139,
21-26
42.
Sipos, L.,
and von Heijne, G.
(1993)
Eur. J. Biochem.
213,
1333-1340
43.
von Heijne, G.
(1992)
J. Mol. Biol.
225,
487-494
44.
Tschantz, W. R.,
Sung, M.,
Delgado-Partin, V. M.,
and Dalbey, R. E.
(1993)
J. Biol. Chem.
268,
27349-27354
45.
Nunnari, J.,
Fox, T. D.,
and Walter, P.
(1993)
Science
262,
1997-2004
46.
Bolhuis, A.,
Tjalsma, H.,
Stephenson, K.,
Harwood, C. R.,
Venema, G.,
Bron, S.,
and van Dijl, J. M.
(1999)
J. Biol. Chem.
274,
15865-15868
47.
Klenotic, P. A.,
Carlos, J. L.,
Samuelson, J. C.,
Schuenemann, T. A.,
Tschantz, W. R.,
Paetzel, M.,
Strynadka, N. C. J.,
and Dalbey, R. E.
(2000)
J. Biol. Chem.
275,
6490-6498
48.
Stragier, P.,
and Losick, R.
(1996)
Annu. Rev. Genet.
30,
297-241
49.
Talarico, T. L.,
Dev, I. K.,
Bassford, P. J.,
and Ray, P. H.
(1991)
Biochem. Biophys. Res. Commun.
181,
650-656
50.
Lin, L. L.,
and Little, J. W.
(1989)
J. Mol. Biol.
210,
439-452
51.
Black, M. T.
(1993)
J. Bacteriol.
175,
4957-4961
52.
Little, J. W.
(1993)
J. Bacteriol.
175,
4943-4950
53.
Dalbey, R. E.,
and von Heijne, G.
(1992)
Trends Biochem. Sci.
17,
474-478
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Zahner and J. R. Scott SipA Is Required for Pilus Formation in Streptococcus pyogenes Serotype M3 J. Bacteriol., January 15, 2008; 190(2): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. M. Ng, B. Chaban, D. J. VanDyke, and K. F. Jarrell Archaeal signal peptidases Microbiology, February 1, 2007; 153(2): 305 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fine, V. Irihimovitch, I. Dahan, Z. Konrad, and J. Eichler Cloning, Expression, and Purification of Functional Sec11a and Sec11b, Type I Signal Peptidases of the Archaeon Haloferax volcanii. J. Bacteriol., March 1, 2006; 188(5): 1911 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Bardy, S. Y. M. Ng, D. S. Carnegie, and K. F. Jarrell Site-Directed Mutagenesis Analysis of Amino Acids Critical for Activity of the Type I Signal Peptidase of the Archaeon Methanococcus voltae J. Bacteriol., February 1, 2005; 187(3): 1188 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Scala, F Ariani, F Mari, R Caselli, C Pescucci, I Longo, I Meloni, D Giachino, M Bruttini, G Hayek, et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms J. Med. Genet., February 1, 2005; 42(2): 103 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Imamura, K. Kobayashi, J. Sekiguchi, N. Ogasawara, M. Takeuchi, and T. Sato spoIVH (ykvV), a Requisite Cortex Formation Gene, Is Expressed in Both Sporulating Compartments of Bacillus subtilis J. Bacteriol., August 15, 2004; 186(16): 5450 - 5459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Branda, J. E. Gonzalez-Pastor, E. Dervyn, S. D. Ehrlich, R. Losick, and R. Kolter Genes Involved in Formation of Structured Multicellular Communities by Bacillus subtilis J. Bacteriol., June 15, 2004; 186(12): 3970 - 3979. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tjalsma, H. Antelmann, J. D.H. Jongbloed, P. G. Braun, E. Darmon, R. Dorenbos, J.-Y. F. Dubois, H. Westers, G. Zanen, W. J. Quax, et al. Proteomics of Protein Secretion by Bacillus subtilis: Separating the "Secrets" of the Secretome Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 207 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stephenson, C. Mueller, M. Jiang, and M. Perego Molecular Analysis of Phr Peptide Processing in Bacillus subtilis J. Bacteriol., August 15, 2003; 185(16): 4861 - 4871. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tjalsma, S. Bron, and J. M. van Dijl Complementary Impact of Paralogous Oxa1-like Proteins of Bacillus subtilis on Post-translocational Stages in Protein Secretion J. Biol. Chem., April 25, 2003; 278(18): 15622 - 15632. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tjalsma, A. Bolhuis, J. D. H. Jongbloed, S. Bron, and J. M. van Dijl Signal Peptide-Dependent Protein Transport in Bacillus subtilis: a Genome-Based Survey of the Secretome Microbiol. Mol. Biol. Rev., September 1, 2000; 64(3): 515 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. van Roosmalen, J. D. H. Jongbloed, J.-Y. F. Dubois, G. Venema, S. Bron, and J. M. van Dijl Distinction between Major and Minor Bacillus Signal Peptidases Based on Phylogenetic and Structural Criteria J. Biol. Chem., June 29, 2001; 276(27): 25230 - 25235. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||